Ideas to Action:

Independent research for global prosperity

Publications

Current search

Topic

 

July 24, 2020

Testimony on Critical US Supply Chains Amid the COVID-19 Pandemic

On July 23, 2020, CGD Senior Fellow Prashant Yadav appeared before the House Ways and Means Subcommittee on Trade at a hearing titled “Trade, Manufacturing, and Critical Supply Chains: Lessons From COVID-19.” Yadav’s testimony noted the vulnerabilities in supply chains for medical products clearly exposed by the COVID-19 pandemic and outlined key considerations for US policy toward medical supply chains moving forward.

A cover image of a whole of health look at impacts during the COVID-19 pandemic response
July 1, 2020

Beyond COVID-19: A Whole of Health Look at Impacts During the Pandemic Response

Substantial evidence has emerged relating to the potential magnitude of the indirect health effects of the coronavirus pandemic.This paper provides an overview of the lessons learned from previous outbreaks and economic crises in relation to indirect health effects as well as a framework for adopting a whole of health approach to the COVID response.

An image of a Covid-19 vaccine
June 4, 2020

India’s COVID-19 Testing Capacity Must Grow by a Factor of 10: Here’s How That Can Happen

Diagnostic testing is at the center of the policy debate around COVID-19 interventions in India. As of June 1, 2020, India had conducted approximately 3.8 million tests since it began testing in February, but many experts have noted that testing capacity is still drastically insufficient for the needs of the population.

Prashant Yadav , Abha Mehndiratta , Kalipso Chalkidou , Sidharth Rupani and Krishna Reddy
Image of MVAC vaccines process
May 7, 2020

Leave No One Behind: Using a Benefit-Based Advance Market Commitment to Incentivise Development and Global Supply of COVID-19 Vaccines

The global effort to control the COVID-19 pandemic has seen an exceptional allocation of public and philanthropic funds to advance the development of diagnostics, therapeutics, and vaccines as quickly as possible. While critical, even these significant commitments represent only a “down payment” on a price tag that could eventually exceed $50 billion just to scale the production of vaccines to control this global pandemic—amounts that cannot be raised through traditional donor and philanthropic commitments.

Cover image for MVAC
February 5, 2020

Blueprint for a Market-Driven Value-Based Advance Commitment for Tuberculosis

The market-driven, value-based advance commitment (MVAC) builds on the advance market commitment (AMC) mechanism previously used in global health with several important innovations and improvements. Most crucially, the MVAC is driven by MIC demand rather than donor contributions; is informed by countries’ ability to pay rather than a single, “cost-plus” price; and allows pharmaceutical companies to reap higher revenues from a more effective product. In this report, we apply our new model—the MVAC—to a target product profile (TPP), published by the World Health Organization (WHO) in 2016 and endorsed by BMGF, for a pan-TB regimen.

Cover of Private Distribution Channels for UHC paper
December 12, 2019

Harnessing the Power of Private Distribution Channels for UHC

New technology, better use of data, and entrepreneurial passion in improving distribution channels is reaching a critical mass with the potential to drive extraordinary improvements in availability, affordability, and quality of health products. Global health institutions can play a significant role in further boosting the overall innovation ecosystem for health products distribution. However, most distribution system innovators are missing from global discussions around UHC and access to medicines.

Front cover of aid transitions note
December 10, 2019

Mind the Gaps: Takeaways from Emerging Research and Policy Implications for Aid Transition in Health and Development

As countries grow economically, governments face rapidly growing demands for quality, affordable, accessible, and equitable healthcare and other social services. At the same time, many middle-income countries face the prospect of transitioning away from donor aid, adding pressure to already-constrained public budgets to fill gaps as donor support ramps down. 

Image of sugar coming out of soda can
November 12, 2019

Taxing “Bads”: An Overview of Research Initiatives

This note outlines the organizations and research initiatives currently addressing taxation of tobacco, alcohol, and sugar-sweetened beverages—the “bads”—to help navigate the landscape of existing research and identify gaps and opportunities for further work.

Pages